President Trump's pick to lead the Food and Drug Administration, Heidi Overton, on Thursday will have to convince a handful of skeptical Republican senators to back her nomination.
But the larger biotech world is watching for hints about how she'd lead the agency through a defining era for the sector.
As extreme heat makes afternoons more dangerous, schools, sports teams and outdoor employers are shifting when — and sometimes whether — people can safely be outside.
Why it matters: Adapting to hotter conditions could reshape the American workday while putting a premium on the cooling and energy infrastructure people rely on when outdoor conditions become unsafe.
McDonald's is considering new protein-based products to win over GLP-1 drug users and says that many of its current items are already proving attractive to them.
Why it matters: The food industry is scrambling to adjust to a market in which about 1 in 8 American adults are taking the medication to treat obesity or diabetes, changing their eating habits.
Congress may be going home to campaign — but not before laying the groundwork for possible changes to how Medicare pays doctors.
Why it matters: Wary of yet another headache for patients and physicians, lawmakers are growing more receptive to addressing a long-running complaint about the way the program reimburses physicians.
